Vela Investment Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Vela Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$151.41 - $196.57 $242,104 - $314,315	-1,599 Reduced 46.8%	1,818 $347,000
Q1 2023 May 08, 2023	BUY	$182.66 - $235.53 $16,804 - $21,668	92 Added 2.77%	3,417 $684,000
Q3 2022 Nov 10, 2022	BUY	$138.54 - $232.0 $48,489 - $81,200	350 Added 11.76%	3,325 $666,000
Q1 2022 May 12, 2022	BUY	$127.18 - $173.91 $69,185 - $94,607	544 Added 22.38%	2,975 $486,000
Q4 2021 Feb 09, 2022	BUY	$159.56 - $209.29 $387,890 - $508,783	2,431 New	2,431 $412,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Vela Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vela Investment Management, LLC with notifications on news.